These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10918114)

  • 1. Akathisia and prochlorperazine.
    Sharma AN; Steinberg K; Nelson LS
    Ann Emerg Med; 2000 Aug; 36(2):169-70. PubMed ID: 10918114
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute dystonic reaction secondary to prochlorperazine use in the treatment of hyperemesis gravidarum.
    Beirne M; Fenton J
    Ir J Med Sci; 2007 Mar; 176(1):53-4. PubMed ID: 17849526
    [No Abstract]   [Full Text] [Related]  

  • 3. Prochlorperazine induces akathisia in emergency patients.
    Drotts DL; Vinson DR
    Ann Emerg Med; 1999 Oct; 34(4 Pt 1):469-75. PubMed ID: 10499947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow infusion for the prevention of akathisia induced by prochlorperazine: a randomized controlled trial.
    Vinson DR; Migala AF; Quesenberry CP
    J Emerg Med; 2001 Feb; 20(2):113-9. PubMed ID: 11207403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Akathisia: problematic but preventable.
    Vinson DR
    Ann Emerg Med; 2002 May; 39(5):576. PubMed ID: 11973572
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurologic complications of prochlorperazine.
    Pesola GR; Quinto C
    Ann Emerg Med; 1998 Feb; 31(2):285-6. PubMed ID: 9472196
    [No Abstract]   [Full Text] [Related]  

  • 7. Compatibility of hydromorphone and prochlorperazine, and irritation due to subcutaneous prochlorperazine infusion.
    Trinkle R
    Ann Pharmacother; 1997 Jun; 31(6):789-90. PubMed ID: 9184729
    [No Abstract]   [Full Text] [Related]  

  • 8. Unexpectedly high prevalence of akathisia in cancer patients.
    Kawanishi C; Onishi H; Kato D; Kishida I; Furuno T; Wada M; Hirayasu Y
    Palliat Support Care; 2007 Dec; 5(4):351-4. PubMed ID: 18044412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of respiratory akathisia in a cancer patient: a case report.
    Sunakawa Y; Wada M; Nishida T; Wada M; Araki K; Endo H; Nagashima F; Ichikawa W; Miya T; Onishi H; Narabayashi M; Sasaki Y
    Palliat Support Care; 2008 Mar; 6(1):79-81. PubMed ID: 18282348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diphenhydramine for the prevention of akathisia induced by prochlorperazine: a randomized, controlled trial.
    Vinson DR; Drotts DL
    Ann Emerg Med; 2001 Feb; 37(2):125-31. PubMed ID: 11174228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akathisia associated with prochlorperazine as an antiemetic: a case report.
    Dukoff R; Horak ID; Hassan R; Rosenstein DL
    Ann Oncol; 1996 Jan; 7(1):103. PubMed ID: 9081380
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnostic image (17). Acute dystonia induced by prochlorperazine].
    van Gijn J
    Ned Tijdschr Geneeskd; 2000 Dec; 144(52):2496. PubMed ID: 11155505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapyramidal side effects of antiemetics presenting as psychiatric illness.
    Rodgers C
    Gen Hosp Psychiatry; 1992 May; 14(3):192-5. PubMed ID: 1601295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of adverse reactions to prochlorperazine in the ED.
    Olsen JC; Keng JA; Clark JA
    Am J Emerg Med; 2000 Sep; 18(5):609-11. PubMed ID: 10999579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a simplified instrument for the diagnosis and grading of akathisia in a cohort of patients receiving prochlorperazine.
    Vinson DR
    J Emerg Med; 2006 Aug; 31(2):139-45. PubMed ID: 17044574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous administration of prochlorperazine by 15-minute infusion versus 2-minute bolus does not affect the incidence of akathisia: a prospective, randomized, controlled trial.
    Collins RW; Jones JB; Walthall JD; Chisholm CD; Giles BK; Brizendine EJ; Cordell WH
    Ann Emerg Med; 2001 Nov; 38(5):491-6. PubMed ID: 11679859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability and metabolism of prochlorperazine administered via the buccal and oral delivery route.
    Finn A; Collins J; Voyksner R; Lindley C
    J Clin Pharmacol; 2005 Dec; 45(12):1383-90. PubMed ID: 16291713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study on the antiemetic effect and extrapyramidal symptoms of prochlorperazine versus perospirone for the control of nausea and vomiting due to opioid introduction].
    Yomiya K; Takei D; Kurosawa H; Kono B
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):1037-41. PubMed ID: 23986047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slower infusion of metoclopramide decreases the rate of akathisia.
    Regan LA; Hoffman RS; Nelson LS
    Am J Emerg Med; 2009 May; 27(4):475-80. PubMed ID: 19555621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of prochlorperazine buccal tablets (Bukatel) and metoclopramide oral tablets in the treatment of acute emesis.
    Singh S; Sharma DR; Chaudhary A
    J Indian Med Assoc; 1999 Aug; 97(8):346-7. PubMed ID: 10643185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.